この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。
ビジネス · 1997/4/301 分で読めます
Implantation or Injectable Dosage Form New Animal Drugs; Amikacin Sulfate Injection
ローカル自動翻訳 · 情報源の原言語
概要
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of an abbreviated new animal drug application (ANADA) filed by Phoenix Scientific, Inc. The ANADA provides for the use of amikacin sulfate injection for the treatment of the following conditions in dogs: genitourinary tract infections (cystitis) caused by susceptible strains of Escherichia coli and Proteus spp. and skin and soft tissue infections caused by susceptible strains of Pseudomonas spp. and E. coli.
情報源の原言語: Federal Register — Food and Drug Administration原文の発表を開く →